Teva/Xenon’s Pain Ointment Failure Leaves Sparser Nav1.7 Pipeline

Once highly anticipated as an alternative mechanism for pain, the Nav1.7 target suffered another blow with Teva/Xenon’s failure of TV-45070 in osteoarthritis, though the class may still work in neuropathic pain.